PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.
Industry, Sector and Symbol:
- Sector: Retail/Wholesale
- Industry: Retail - Drugs without Grocery
- Sub-Industry: Internet Retail
- Symbol: NASDAQ:PETS
- CUSIP: 71638210
- Web: www.1800petmeds.com
Capitalization:- Market Cap: $737.84 million
- Outstanding Shares: 20,292,000
Average Prices:- 50 Day Moving Avg: $40.97
- 200 Day Moving Avg: $33.60
- 52 Week Range: $18.90 - $50.90
P/E:- Trailing P/E Ratio: 27.19
- Foreward P/E Ratio: 23.41
- P/E Growth: 2.53
Sales & Book Value:- Annual Revenue: $256.35 million
- Price / Sales: 2.80
- Book Value: $4.88 per share
- Price / Book: 7.24
Dividend:- Annual Dividend: $0.80
- Dividend Yield: 2.2%
Profitability:- EBIDTA: $43.21 million
- Net Margins: 10.34%
- Return on Equity: 28.67%
- Return on Assets: 24.50%
Debt:- Current Ratio: 3.71%
- Quick Ratio: 2.81%
Misc:- Average Volume: 1.10 million shs.
- Beta: 1.03
- Short Ratio: 4.22
Frequently Asked Questions for PetMed Express (NASDAQ:PETS)
What is PetMed Express' stock symbol?
PetMed Express trades on the NASDAQ under the ticker symbol "PETS."
How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?
PetMed Express declared a quarterly dividend on Monday, July 24th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.20 per share on Friday, August 18th. This represents a $0.80 annualized dividend and a yield of 2.26%. The ex-dividend date is Thursday, August 3rd. View PetMed Express' Dividend History.
How were PetMed Express' earnings last quarter?
PetMed Express, Inc. (NASDAQ:PETS) announced its earnings results on Monday, July, 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.07. The business earned $79.66 million during the quarter, compared to analysts' expectations of $77.32 million. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The company's quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 EPS. View PetMed Express' Earnings History.
When will PetMed Express make its next earnings announcement?
Where is PetMed Express' stock going? Where will PetMed Express' stock price be in 2017?
4 brokers have issued 1 year target prices for PetMed Express' shares. Their predictions range from $40.00 to $54.00. On average, they expect PetMed Express' share price to reach $47.00 in the next year. View Analyst Ratings for PetMed Express.
Are investors shorting PetMed Express?
PetMed Express saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 6,576,207 shares, an increase of 105.9% from the August 15th total of 3,193,474 shares. Based on an average daily volume of 3,090,918 shares, the short-interest ratio is currently 2.1 days. Currently, 33.3% of the shares of the company are sold short.
Who are some of PetMed Express' key competitors?
Some companies that are related to PetMed Express include Bob Evans Farms (BOBE), BMC Stock Holdings (BMCH), GMS (GMS), Diplomat Pharmacy (DPLO), Group 1 Automotive (GPI), J.C. Penney Company, Inc. Holding Company (JCP), Asbury Automotive Group (ABG), Shake Shack (SHAK), Weis Markets (WMK), Chico's FAS (CHS), Lumber Liquidators Holdings (LL), Sonic Corp. (SONC), Wingstop (WING), Systemax (SYX), Abercrombie & Fitch Company (ANF), SpartanNash Company (SPTN), Ethan Allen Interiors (ETH) and Sears Holdings Corporation (SHLD).
Who are PetMed Express' key executives?
PetMed Express' management team includes the folowing people:
- Robert C. Schweitzer, Independent Chairman of the Board
- Menderes Akdag, President, Chief Executive Officer, Director
- Bruce S. Rosenbloom, Chief Financial Officer, Treasurer
- Frank J. Formica, Independent Director
- Gian M. Fulgoni, Independent Director
- Ronald J. Korn, Independent Director
Who owns PetMed Express stock?
PetMed Express' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.15%), Renaissance Technologies LLC (8.12%), Vanguard Group Inc. (6.41%), Dimensional Fund Advisors LP (4.24%), State Street Corp (3.19%) and Acadian Asset Management LLC (2.27%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for PetMed Express.
Who sold PetMed Express stock? Who is selling PetMed Express stock?
PetMed Express' stock was sold by a variety of institutional investors in the last quarter, including Uniplan Investment Counsel Inc., Numeric Investors LLC, Renaissance Technologies LLC, LSV Asset Management, TD Asset Management Inc., Wells Fargo & Company MN, Rothschild Investment Corp IL and BlackRock Inc.. Company insiders that have sold PetMed Express stock in the last year include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for PetMed Express.
Who bought PetMed Express stock? Who is buying PetMed Express stock?
PetMed Express' stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Oaktop Capital Management II L.P., Vanguard Group Inc., Koch Industries Inc., Lord Abbett & CO. LLC, EAM Investors LLC, WBI Investments Inc. and Prudential Financial Inc.. View Insider Buying and Selling for PetMed Express.
How do I buy PetMed Express stock?
Shares of PetMed Express can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PetMed Express' stock price today?
One share of PetMed Express stock can currently be purchased for approximately $35.35.
MarketBeat Community Rating for PetMed Express (NASDAQ PETS)MarketBeat's community ratings are surveys of what our community members think about PetMed Express and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for PetMed Express (NASDAQ:PETS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 2 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | $47.00 (32.96% upside) |
Analysts' Ratings History for PetMed Express (NASDAQ:PETS)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/24/2017 | Sidoti | Upgrade | Neutral -> Buy | $47.00 | High |  |
| 8/21/2017 | Craig Hallum | Reiterated Rating | Hold | $43.00 -> $40.00 | High | |
| 7/26/2017 | Noble Financial | Reiterated Rating | Hold | | Low | |
| 7/24/2017 | Northcoast Research | Upgrade | Neutral -> Buy | $54.00 | High | |
| 8/16/2016 | Credit Suisse Group | Reiterated Rating | Sell | $13.00 | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for PetMed Express (NASDAQ:PETS)Earnings History by Quarter for PetMed Express (NASDAQ PETS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/23/2017 | | $0.31 | | | | | N/A | |
| 7/24/2017 | Q1 2018 | $0.38 | $0.45 | $77.32 million | $79.66 million | View | N/A | |
| 5/8/2017 | Q4 17 | $0.26 | $0.37 | $56.53 million | $63.03 million | View | Listen | |
| 1/23/2017 | Q3 2017 | $0.25 | $0.24 | $52.70 million | $52.90 million | View | N/A | |
| 10/24/2016 | Q2 | $0.26 | $0.24 | $58.47 million | $60.80 million | View | N/A | |
| 7/25/2016 | Q1 | $0.31 | $0.32 | $72.90 million | $72.49 million | View | N/A | |
| 5/9/2016 | Q4 | $0.25 | $0.27 | $50.20 million | $55.40 million | View | N/A | |
| 1/25/2016 | Q316 | $0.25 | $0.24 | $49.28 million | $50.90 million | View | Listen | |
| 10/19/2015 | Q216 | $0.20 | $0.22 | $58.34 million | $56.70 million | View | Listen | |
| 7/20/2015 | Q116 | $0.28 | $0.29 | $73.04 million | $71.60 million | View | N/A | |
| 5/4/2015 | Q415 | $0.25 | $0.25 | $49.11 million | $50.00 million | View | N/A | |
| 1/20/2015 | Q315 | $0.24 | $0.24 | $49.26 million | $49.30 million | View | N/A | |
| 10/20/2014 | Q215 | $0.21 | $0.19 | $61.22 million | $57.60 million | View | Listen | |
| 7/21/2014 | Q115 | $0.25 | $0.25 | $74.25 million | $72.50 million | View | N/A | |
| 5/5/2014 | Q414 | $0.22 | $0.23 | $55.02 million | $48.60 million | View | N/A | |
| 1/21/2014 | Q214 | $0.23 | $0.23 | $52.06 million | $50.10 million | View | N/A | |
| 10/21/2013 | Q213 | $0.22 | $0.20 | $60.33 million | $80.50 million | View | N/A | |
| 7/22/2013 | Q1 2013 | $0.22 | $0.24 | $69.55 million | $74.20 million | View | N/A | |
| 5/6/2013 | Q4 2012 | $0.21 | $0.23 | $55.31 million | $51.10 million | View | N/A | |
| 1/22/2013 | Q3 2012 | $0.17 | $0.23 | $49.97 million | $49.60 million | View | N/A | |
| 10/22/2012 | | $0.17 | $0.20 | | | View | N/A | |
| 7/23/2012 | | $0.23 | $0.20 | | | View | N/A | |
| 5/7/2012 | | $0.18 | $0.20 | | | View | N/A | |
| 1/23/2012 | | $0.16 | $0.19 | | | View | N/A | |
| 10/24/2011 | | $0.15 | $0.19 | | | View | N/A | |
| 7/18/2011 | | $0.24 | $0.22 | | | View | N/A | |
| 5/9/2011 | | $0.23 | $0.19 | | | View | N/A | |
| 1/24/2011 | | $0.20 | $0.20 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for PetMed Express (NASDAQ:PETS)2017 EPS Consensus Estimate: $1.06
2018 EPS Consensus Estimate: $1.36
2019 EPS Consensus Estimate: $1.51
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.30 | $0.30 | $0.30 |
| Q2 2017 | 2 | $0.23 | $0.28 | $0.26 |
| Q3 2017 | 2 | $0.23 | $0.26 | $0.25 |
| Q4 2017 | 2 | $0.25 | $0.26 | $0.26 |
| Q1 2018 | 2 | $0.40 | $0.40 | $0.40 |
| Q2 2018 | 2 | $0.28 | $0.28 | $0.28 |
| Q3 2018 | 2 | $0.27 | $0.29 | $0.28 |
| Q4 2018 | 2 | $0.38 | $0.41 | $0.40 |
| Q1 2019 | 2 | $0.47 | $0.49 | $0.48 |
| Q2 2019 | 2 | $0.30 | $0.30 | $0.30 |
| Q3 2019 | 2 | $0.29 | $0.31 | $0.30 |
| Q4 2019 | 2 | $0.40 | $0.45 | $0.43 |
(Data provided by Zacks Investment Research)
Current Dividend Information for PetMed Express (NASDAQ:PETS)| Most Recent Dividend: | 8/18/2017 |
| Annual Dividend: | $0.80 |
| Dividend Yield: | 2.26% |
| Payout Ratio: | 61.54% (Trailing 12 Months of Earnings)
56.74% (Based on This Year's Estimates)
52.98% (Based on Next Year's Estimates)
|
Dividend History by Quarter for PetMed Express (NASDAQ PETS)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/24/2017 | quarterly | $0.20 | 1.66% | 8/3/2017 | 8/7/2017 | 8/18/2017 |
| 5/8/2017 | quarterly | $0.20 | | 5/17/2017 | 5/19/2017 | 5/26/2017 |
| 1/23/2017 | quarterly | $0.19 | 3.61% | 2/2/2017 | 2/6/2017 | 2/17/2017 |
| 10/24/2016 | quarterly | $0.19 | 3.84% | 11/3/2016 | 11/7/2016 | 11/18/2016 |
| 7/25/2016 | quarterly | $0.19 | 3.71% | 8/4/2016 | 8/8/2016 | 8/19/2016 |
| 5/9/2016 | quarterly | $0.19 | 3.9% | 5/18/2016 | 5/20/2016 | 5/27/2016 |
| 1/25/2016 | quarterly | $0.18 | 4.04% | 2/4/2016 | 2/8/2016 | 2/19/2016 |
| 10/19/2015 | quarterly | $0.18 | 4.28% | 10/29/2015 | 11/2/2015 | 11/13/2015 |
| 7/20/2015 | quarterly | $0.18 | 4.23% | 7/30/2015 | 8/3/2015 | 8/14/2015 |
| 5/4/2015 | quarterly | $0.18 | 4.41% | 5/13/2015 | 5/15/2015 | 5/22/2015 |
| 1/20/2015 | quarterly | $0.17 | 4.2% | 1/30/2015 | 2/3/2015 | 2/13/2015 |
| 10/20/2014 | quarterly | $0.17 | | 10/30/2014 | 11/3/2014 | 11/14/2014 |
| 7/21/2014 | quarterly | $0.17 | 4.79% | 7/31/2014 | 8/4/2014 | 8/15/2014 |
| 5/5/2014 | quarterly | $0.17 | 5.22% | 5/14/2014 | 5/16/2014 | 5/23/2014 |
| 1/30/2014 | quarterly | $0.17 | 5.14% | 2/10/2014 | 2/12/2014 | 2/21/2014 |
| 10/28/2013 | quarterly | $0.17 | 4.56% | 11/6/2013 | 11/8/2013 | 11/22/2013 |
| 7/26/2013 | quarterly | $0.17 | 4.16% | 8/8/2013 | 8/12/2013 | 8/23/2013 |
| 5/3/2013 | quarterly | $0.15 | 4.65% | 5/13/2013 | 5/15/2013 | 5/24/2013 |
| 1/28/2013 | quarterly | $0.15 | 4.64% | 2/6/2013 | 2/8/2013 | 2/22/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for PetMed Express (NASDAQ:PETS)Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 78.91%
Insider Trades by Quarter for PetMed Express (NASDAQ:PETS)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/1/2017 | Robert C Schweitzer | Director | Sell | 2,500 | $49.18 | $122,950.00 | |
| 7/28/2017 | Ronald J Korn | Director | Sell | 5,000 | $48.18 | $240,900.00 | |
| 7/27/2017 | Bruce S Rosenbloom | CFO | Sell | 6,833 | $50.18 | $342,879.94 | |
| 7/27/2017 | Robert C Schweitzer | Director | Sell | 5,000 | $48.60 | $243,000.00 | |
| 5/16/2017 | Frank J Formica | Director | Sell | 5,000 | $35.32 | $176,600.00 | |
| 5/10/2017 | Gian Fulgoni | Director | Sell | 35,000 | $32.22 | $1,127,700.00 | |
| 5/8/2017 | Bruce S Rosenbloom | Insider | Sell | 9,000 | $27.00 | $243,000.00 | |
| 5/1/2017 | Bruce S Rosenbloom | Insider | Sell | 1,500 | $24.00 | $36,000.00 | |
| 12/13/2016 | Menderes Akdag | CEO | Sell | 10,000 | $23.00 | $230,000.00 | |
| 12/9/2016 | Bruce S Rosenbloom | Insider | Sell | 1,500 | $23.00 | $34,500.00 | |
| 12/7/2016 | Menderes Akdag | CEO | Sell | 3,107 | $22.75 | $70,684.25 | |
| 11/25/2016 | Menderes Akdag | CEO | Sell | 6,274 | $22.25 | $139,596.50 | |
| 11/16/2016 | Frank J Formica | Director | Sell | 10,000 | $21.75 | $217,500.00 | |
| 11/14/2016 | Bruce S Rosenbloom | Insider | Sell | 3,000 | $21.75 | $65,250.00 | |
| 11/14/2016 | Menderes Akdag | CEO | Sell | 40,000 | $21.63 | $865,200.00 | |
| 10/10/2016 | Bruce S Rosenbloom | Insider | Sell | 1,500 | $21.00 | $31,500.00 | |
| 10/10/2016 | Menderes Akdag | CEO | Sell | 10,000 | $21.00 | $210,000.00 | |
| 9/22/2016 | Menderes Akdag | CEO | Sell | 10,000 | $20.75 | $207,500.00 | |
| 8/12/2016 | Bruce S Rosenbloom | Insider | Sell | 8,000 | $20.38 | $163,040.00 | |
| 8/11/2016 | Robert C Schweitzer | Director | Sell | 3,000 | $20.59 | $61,770.00 | |
| 8/9/2016 | Robert C Schweitzer | Director | Sell | 4,500 | $20.52 | $92,340.00 | |
| 8/1/2016 | Ronald J Korn | Director | Sell | 4,000 | $20.76 | $83,040.00 | |
| 5/9/2016 | Bruce S Rosenbloom | CFO | Sell | 5,500 | $19.54 | $107,470.00 | |
| 3/30/2016 | Bruce S Rosenbloom | CFO | Sell | 1,500 | $18.00 | $27,000.00 | |
| 3/14/2016 | Bruce S Rosenbloom | CFO | Sell | 3,000 | $17.25 | $51,750.00 | |
| 2/22/2016 | Ronald J Korn | Director | Sell | 5,000 | $16.76 | $83,800.00 | |
| 1/22/2016 | Bruce S Rosenbloom | CFO | Sell | 750 | $18.50 | $13,875.00 | |
| 11/20/2015 | Ronald J Korn | Director | Sell | 1,000 | $17.01 | $17,010.00 | |
| 7/14/2015 | Bruce S Rosenbloom | CFO | Sell | 400 | $18.25 | $7,300.00 | |
| 7/13/2015 | Bruce S Rosenbloom | CFO | Sell | 100 | $18.25 | $1,825.00 | |
| 6/19/2015 | Bruce S Rosenbloom | CFO | Sell | 1,000 | $17.88 | $17,880.00 | |
| 6/19/2015 | Menderes Akdag | CEO | Sell | 8,000 | $17.75 | $142,000.00 | |
| 6/4/2015 | Menderes Akdag | CEO | Sell | 9,930 | $17.50 | $173,775.00 | |
| 5/8/2015 | Frank J Formica | Director | Sell | 7,500 | $16.51 | $123,825.00 | |
| 4/23/2015 | Menderes Akdag | CEO | Sell | 10,000 | $17.25 | $172,500.00 | |
| 4/20/2015 | Menderes Akdag | CEO | Sell | 10,000 | $17.00 | $170,000.00 | |
| 4/13/2015 | Menderes Akdag | CEO | Sell | 7,499 | $16.75 | $125,608.25 | |
| 4/13/2015 | Ronald J Korn | Director | Sell | 2,000 | $16.75 | $33,500.00 | |
| 4/8/2015 | Menderes Akdag | CEO | Sell | 2,501 | $16.75 | $41,891.75 | |
| 3/30/2015 | Menderes Akdag | CEO | Sell | 10,000 | $16.50 | $165,000.00 | |
| 3/25/2015 | Ronald J Korn | Director | Sell | 2,000 | $16.25 | $32,500.00 | |
| 1/21/2015 | Menderes Akdag | CEO | Sell | 60,000 | $15.63 | $937,800.00 | |
| 1/20/2015 | Bruce S Rosenbloom | CFO | Sell | 2,167 | $15.40 | $33,371.80 | |
| 8/15/2014 | Ronald J Korn | Director | Sell | 2,000 | $14.13 | $28,260.00 | |
| 7/22/2014 | Bruce S Rosenbloom | CFO | Sell | 1,000 | $14.13 | $14,130.00 | |
| 7/21/2014 | Bruce S Rosenbloom | CFO | Sell | 500 | $14.00 | $7,000.00 | |
| 6/12/2014 | Bruce S Rosenbloom | CFO | Sell | 1,500 | $13.50 | $20,250.00 | |
| 9/13/2013 | Menderes Akdag | CEO | Sell | 10,000 | $17.00 | $170,000.00 | |
| 9/11/2013 | Bruce S Rosenbloom | CFO | Sell | 6,666 | $16.21 | $108,055.86 | |
| 8/14/2013 | Ronald Korn | Director | Sell | 1,000 | $16.25 | $16,250.00 | |
| 8/12/2013 | Ronald Korn | Director | Sell | 1,000 | $16.18 | $16,180.00 | |
| 7/31/2013 | Frank J Formica | Director | Sell | 7,000 | $16.39 | $114,730.00 | |
| 7/22/2013 | Bruce S Rosenbloom | CFO | Sell | 6,250 | $16.74 | $104,625.00 | |
| 3/6/2013 | Ronald J Korn | Director | Sell | 2,000 | $13.50 | $27,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for PetMed Express (NASDAQ:PETS)
Latest Headlines for PetMed Express (NASDAQ:PETS)
| Source: |
|
| Date | Headline |
|---|
 | SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PetMed Express, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - September 20 at 7:39 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline - October 24, 2017
finance.yahoo.com - September 19 at 6:28 AM |
 | PetMed Express, Inc. (PETS) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 18 at 2:44 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline - October 24, 2017
finance.yahoo.com - September 17 at 6:46 AM |
| At $36.71, Is PetMed Express Inc (PETS) A Buy?
finance.yahoo.com - September 17 at 6:46 AM |
| Q2 2018 EPS Estimates for PetMed Express, Inc. Cut by Northcoast Research (PETS)
www.americanbankingnews.com - September 15 at 12:58 PM |
| PetMed Express, Inc. (PETS) Short Interest Up 105.9% in August
www.americanbankingnews.com - September 14 at 1:46 AM |
 | Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action ... - Business Wire (press release)
www.businesswire.com - September 12 at 8:30 AM |
 | PETMED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100000 of ... - GlobeNewswire (press release)
globenewswire.com - September 10 at 6:23 AM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PetMed Express, Inc. of Class Action Lawsuit and Upcoming Deadline - PETS
finance.yahoo.com - September 10 at 6:23 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - September 9 at 7:17 AM |
| PETS LOSS NOTICE: Rosen Law Firm Reminds PetMed Express, Inc. Investors of Important Deadline in Class Action – PETS
finance.yahoo.com - September 9 at 7:17 AM |
| PetMed Express, Inc. : PETS-US: Dividend Analysis : August 07th, 2017 (record date) : By the numbers : September 9, 2017
finance.yahoo.com - September 9 at 7:17 AM |
 | PETMED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)
feeds.benzinga.com - September 8 at 11:58 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PetMed Express, Inc. and Certain Officers – PETS
feeds.benzinga.com - September 7 at 6:54 PM |
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In PetMed Express, Inc. (Nasdaq:PETS) To Contact Brower Piven Before The Lead Plaintiff Deadline
finance.yahoo.com - September 7 at 7:35 AM |
| Analysts Expect Petmed Express Inc (PETS) Will Post Quarterly Sales of $64.53 Million
www.americanbankingnews.com - September 7 at 2:00 AM |
| Why PetMed Express Inc.'s Shares Plunged in August
finance.yahoo.com - September 5 at 5:13 PM |
 | Why PetMed Express Inc.'s Shares Plunged in August
www.fool.com - September 5 at 10:19 AM |
| ValuEngine Upgrades PetMed Express, Inc. (PETS) to Buy
www.americanbankingnews.com - September 2 at 6:20 PM |
 | PETMED EXPRESS INC
www.finanznachrichten.de - September 2 at 7:23 AM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - September 2 at 7:23 AM |
 | Technical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma
www.bizjournals.com - September 1 at 7:12 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of PetMed Express, Inc. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - August 31 at 8:41 AM |
| Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against PetMed Express, Inc.
finance.yahoo.com - August 30 at 7:55 AM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff Deadline: October 24, 2017
finance.yahoo.com - August 30 at 7:55 AM |
| PETMED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)
finance.yahoo.com - August 30 at 7:55 AM |
| Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against PetMed Express, Inc. (PETS)
finance.yahoo.com - August 30 at 7:55 AM |
| Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against PetMed Express, Inc. (PETS)
feeds.benzinga.com - August 29 at 8:49 PM |
| Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against PetMed Express, Inc.
feeds.benzinga.com - August 29 at 3:49 PM |
| ETFs with exposure to PetMed Express, Inc. : August 28, 2017
finance.yahoo.com - August 29 at 6:37 AM |
| Why Is PetMed (PETS) Up 16.6% Since the Last Earnings Report? - Yahoo Finance
finance.yahoo.com - August 27 at 5:42 AM |
| PETS Investor Alert: Hagens Berman Alerts Investors in PetMed Express of Investigation into Possible Securities Law Violations
www.bizjournals.com - August 26 at 8:14 AM |
 | PetMed Express (PETS) Releases Further Information Contradicting Short Report
www.streetinsider.com - August 26 at 8:14 AM |
| Glancy Prongay & Murray Files a Securities Class Action on Behalf of PetMed Express, Inc. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - August 26 at 8:14 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of PetMed Express, Inc. Investors
finance.yahoo.com - August 25 at 9:55 AM |
| PetMed Express D/B/A 1-800-PetMeds Releases Further Information Contradicting the Defamatory Anonymous “Report”
finance.yahoo.com - August 25 at 9:55 AM |
| Online pet pharmacy fires back at short-seller’s accusation that it’s exploiting opioid epidemic
finance.yahoo.com - August 25 at 9:55 AM |
| PetMed Express, Inc. (PETS) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - August 24 at 12:02 PM |
 | AZRX To Report Data In Sep., Long & Short Of PETS, IMUC Plunges, CLDX On Watch - Nasdaq
www.nasdaq.com - August 24 at 10:57 AM |
| Why Is PetMed (PETS) Up 16.6% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - August 24 at 10:57 AM |
 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS - PR Newswire (press release)
www.prnewswire.com - August 24 at 10:57 AM |
 | PetMed Express continues slide, down 14% - Seeking Alpha
seekingalpha.com - August 24 at 10:57 AM |
| PETMED INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates PetMed Express, Inc. for Possible Securities Fraud - (PETS)
finance.yahoo.com - August 24 at 10:56 AM |
| Why Is PetMed (PETS) Up 16.6% Since the Last Earnings Report?
finance.yahoo.com - August 24 at 10:56 AM |
| Is the Options Market Predicting a Spike in PetMed (PETS) Stock?
finance.yahoo.com - August 24 at 10:56 AM |
| PetMed Express, Inc. (PETS) Upgraded by Sidoti to Buy
www.americanbankingnews.com - August 24 at 10:56 AM |
| Faruqi & Faruqi, LLP is Investigating PetMed Express, Inc. (PETS) on Behalf of its Shareholders
finance.yahoo.com - August 24 at 10:56 AM |
| PetMed Express takes issue with "false and defamatory" report; stock rebounds 15% from session low
seekingalpha.com - August 23 at 3:34 PM |
| Jim Cramer Gives His Opinion On Advance Auto Parts And Petmed Express - Benzinga
www.benzinga.com - August 23 at 10:13 AM |
PetMed Express (PETS) Chart for Wednesday, September, 20, 2017
